INTRODUCTION
============

Mammalian red blood cells (RBCs) maintain their shape despite being repeatedly exposed to mechanical stress while passing through capillaries. Beneath their plasma membrane, RBCs possess durable and elastic structures composed of spectrin-actin cytoskeleton ([@B25]). This membrane cytoskeleton is arranged as a quasi-hexagonal lattice in which short actin filaments serve as a central joint bridging spectrin molecules ([@B24]). This actin cytoskeleton is also associated with accessory proteins to form the extended spectrin-actin network ([@B11]); these actin-associated proteins also control the size/length of the lattice structure ([@B28]). This cytoskeletal architecture is established before maturation of RBCs ([@B23]), and the organization is maintained for tens of days. Disruption of the lattice structure leads to membrane instability and alterations of RBC shape, thereby impairing the physiological functions of RBCs ([@B27]). For instance, mice lacking the cytoskeletal protein 4.1R showed moderate hemolytic anemia with abnormal morphology of RBCs, reduced membrane stability ([@B35]), and disrupted membrane cytoskeleton ([@B33]). In addition, the RBCs of tropomodulin 1--null mice exhibited increased osmotic fragility and mild spherocytic anemia with an abnormal membrane cytoskeleton ([@B28]). Furthermore, dysfunction of actin filaments results in altered membrane deformability ([@B13]).

Tubulin tyrosine ligase--like 4 (TTLL4) is a member of the tubulin tyrosine ligase--like (TTLL) protein family. This family comprises 13 members, all of which contain an ∼190--amino acid core TTL domain ([@B18]; [@B15]). TTLL4 belongs to a subfamily of the TTLL family along with eight other members, which catalyze glutamylation ([@B18]; [@B15], [@B14]; [@B16]; [@B38]). Glutamylation, covalent attachment of glutamic acids to the side chain of glutamic acid residues in target proteins ([@B8]), occurs on tubulin and nontubulin proteins ([@B32]). Each of the TTLLs involved in glutamylation has different preferences for the initiation or elongation of glutamylation, as well as different substrate specificities ([@B15]; [@B38]). TTLL4 has strong glutamylation-initiating activity and broad substrate specificity, targeting various nontubulin proteins such as nucleosome assembly protein 1 (NAP1) and β-tubulin ([@B38], [@B37]). TTLL4 is highly expressed in the bone marrow, a hematopoietic tissue ([@B15]; [@B40]). A recent study reported abnormal development of hematopoietic cells when TTLL4 was overexpressed in the bone marrow ([@B40]).

In this study, we report the abnormal membrane cytoskeletal architecture in RBCs of *Ttll4*-knockout (KO) mice.

RESULTS
=======

Blood cell counts in *Ttll4*-KO mice are not significantly different from those of wild-type controls
-----------------------------------------------------------------------------------------------------

We obtained a candidate line of *Ttll4*-deficient mice in which an allele of *Ttll4* was trapped by a β-geo gene-trapping vector. Mouse *Ttll4* consists of 21 exons. In the candidate line of *Ttll4*-deficient mice, *Ttll4* was disrupted by insertion of the trapping vector between exons 1 and 2, which were placed upstream of exon 3 harboring the ATG start codon ([Figure 1A](#F1){ref-type="fig"}). *Ttll4* heterozygotes were interbred to obtain *Ttll4*-null mice, and the genotypes were then determined by PCR ([Figure 1B](#F1){ref-type="fig"}). Trapping of *Ttll4* in KO mice was confirmed by reverse transcription PCR with cDNA generated from total RNA extracted from the testis and muscle tissues of wild-type and *Ttll4*-null mice. The primers designed to amplify a 550--base pair region between exons 2 and 7 of *Ttll4* cDNA revealed a band of the expected size from wild-type (+/+) tissues but failed to detect a transcript band from a knockout (−/−) littermate ([Figure 1C](#F1){ref-type="fig"}). Litter analysis revealed no gross abnormalities in litter size and the genotypic ratio of the pups ([Figure 1D](#F1){ref-type="fig"}; *p* = 0.795 by chi-square test). Next we examined *Ttll4*-trapped homozygous mice using an anti-TTLL4 polyclonal antibody raised against the C-terminal domain of TTLL4. In the bone marrow, a 130-kDa protein band was detected in the wild-type control, whereas this band was absent in homozygous *Ttll4*-deficient mice ([Figure 1E](#F1){ref-type="fig"}). In the spleen, a 100-kDa splice variant was expressed in wild-type animals, whereas its expression was completely absent in *Ttll4*-deficient mice ([Figure 1E](#F1){ref-type="fig"}). These results demonstrated that mice containing *Ttll4* trapped by the vector were *Ttll4*-null, that is, *Ttll4*-KO animals. We failed to detect the expression of TTLL4 in RBCs, even in wild-type mice ([Figure 1E](#F1){ref-type="fig"}).

![Disruption of *Ttll4* gene. (A) Schematic of *Ttll4* gene targeting. Arrows indicate primers for genotyping PCR. (B) Genotyping PCR showing *Ttll4* +/+ (wild type), +/− (heterozygote), and −/− (knockout). The wild-type allele was amplified as a 300--base pair fragment. The trapped allele was amplified as a 500--base pair fragment. (C) Total RNA prepared from wild-type (+/+) and knockout (−/−) testis and muscle was reverse-transcribed and then used for PCR amplification with primers specific for *Ttll4*. No amplification product (550 base pairs) for *Ttll4* was observed in knockout mice. Glyceraldehyde-3-phosphate dehydrogenase was used as a control. (D) Litter analysis showing the frequency of appearance of offspring of each genotype produced by interbreeding of *Ttll4+/*− mice. The sum of all the offspring produced from 21 matings for each genotype is shown. Mice 3--6 mo of age were used for mating. (E) Western blot analyses showing expression of TTLL4 protein in different tissues. Actin was used as a loading control.](535fig1){#F1}

Because TTLL4 is highly expressed in the bone marrow, we first examined the hematological parameters of the mice. The number of RBCs and reticulocytes was comparable between *Ttll4*-KO mice and wild-type controls, with no statistically significant differences detected ([Table 1](#T1){ref-type="table"}). The number of white blood cells was also comparable between *Ttll4*-KO mice and wild-type controls and did not show a significant difference ([Table 1](#T1){ref-type="table"}). The number of platelets in *Ttll4*-KO mice was not significantly different from that in wild-type mice ([Table 1](#T1){ref-type="table"}). Furthermore, there were no differences in other blood cell parameters, such as red cell distribution width, hemoglobin, hematocrit, mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and osmotic fragility between *Ttll4*-KO and wild-type mice ([Table 1](#T1){ref-type="table"} and Supplemental Figure S1, A and B). Moreover, we detected no overt differences in the ektacytometry analysis of *Ttll4*-KO RBCs and wild-type RBCs. The deformability index of *Ttll4*-KO RBCs was comparable to that of wild-type RBCs (Supplemental Figure S1C).

###### 

Comparison of hematological analysis between wild-type and *Ttll4*-KO mice.

  Hematological parameter   Wild type        *Ttll4*-KO
  ------------------------- ---------------- ---------------
  RBC count (×10^4^/µl)     889.75 ± 36.31   882 ± 26.21
  Reticulocytes (%)         2.44 ± 0.44      3.36 ± 0.61
  WBC count (×10^2^/µl)     129.2 ± 19.33    133.7 ± 28.8
  PLT count (×10^4^/µl)     42.675 ± 10.57   49.1 ± 23.48
  RDW (%)                   13.05 ± 0.18     14 ± 0.7
  HGB (g/dl)                14.575 ± 0.37    14.47 ± 0.24
  HCT (%)                   42.375 ± 0.89    43 ± 0.59
  MCV (fl)                  47.75 ± 1.07     48.85 ± 1.41
  MCH (pg)                  16.45 ± 0.35     16.45 ± 0.28
  MCHC (g/dl)               34.375 ± 0.23    33.675 ± 0.47

One-year-old female mice were used for analysis. Data are shown as mean ± SEM of three individual experiments. For reticulocytes data are shown as mean ± SEM of six individual experiments. RBC, red blood cell; WBC, white blood cell; PLT, platelets; RDW, red cell distribution width; HGB, hemoglobin; HCT, hematocrit; MCV, mean cell volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration.

*Ttll4*-KO RBCs have larger average diameters in the smear test
---------------------------------------------------------------

In Giemsa-stained blood cell smears, we observed an overt difference in the morphology of RBCs between *Ttll4*-KO and wild-type mice. The *Ttll4*-KO RBCs appeared larger than wild-type RBCs ([Figure 2A](#F2){ref-type="fig"}). A histogram of the diameters of RBCs revealed higher values for the KO mice than for the wild type ([Figure 2B](#F2){ref-type="fig"}). The average diameter of *Ttll4*-KO RBCs was significantly larger than that of wild-type RBCs (5.77 µm in *Ttll4*-KO vs. 5.37 µm in wild type; *p* = 0.017; [Figure 2C](#F2){ref-type="fig"}). In addition, the average diameters of RBCs calculated from each individual *Ttll4*-KO mouse showed much higher variance than those of wild-type mice: the SD was 0.19 μm for *Ttll4*-KO versus 0.05 μm for wild type; the coefficient of variance was 0.03 for *Ttll4*-KO versus 0.01 for wild type ([Figure 2C](#F2){ref-type="fig"}).

![RBC morphology of wild-type and *Ttll4*-KO mice under normal conditions. (A) Giemsa-stained RBCs. Scale bar, 10 μm. (B) Histogram showing the distribution of RBC diameters. The number of RBCs tested: 968 from three independent wild-type animals and 1290 from four independent *Ttll4*-KO mice. (C) Comparison of average diameter of RBCs in individual animals of wild-type (*N* = 3) and *Ttll4*-KO (*N* = 4) mice. Data are shown as mean ± SEM (\**p* \< 0.05). (D) Scanning electron micrographs of RBCs of wild-type and *Ttll4*-KO mice. Scale bar, 4 μm. (E) Flow cytometry features of wild-type and *Ttll4*-KO RBCs. Mice 8--12 mo of age regardless of the sex were used for each experiment.](535fig2){#F2}

To analyze the detailed morphology of *Ttll4*-KO and wild-type RBCs, we observed glutaraldehyde-fixed RBCs by scanning electron microscopy (SEM). Surprisingly, the overall morphology of *Ttll4*-KO RBCs was comparable to that of wild-type RBCs ([Figure 2D](#F2){ref-type="fig"}). We further examined the sizes of RBCs using fluorescence-activated cell sorting (FACS) analysis after labeling intact RBCs with fluorescent anti-Ter119 antibodies. RBC sizes were comparable between *Ttll4*-KO and wild-type mice, similar to the SEM results ([Figure 2E](#F2){ref-type="fig"}).

*Ttll4*-KO RBCs are vulnerable to oxidative stress
--------------------------------------------------

To further determine whether the integrity of RBC morphology under stressful conditions depends on the TTLL4 enzyme, we prepared a hemolytic anemic mouse model of both wild-type and *Ttll4*-KO mice by injecting 20 mg/kg phenylhydrazine (PHZ) into the mouse peritoneal cavity and observed the changes in RBCs 2 d later. Under PHZ-induced oxidative stress, *Ttll4*-KO mice showed remarked hemolysis, as observed in Giemsa-stained blood smears ([Figure 3A](#F3){ref-type="fig"}, arrowheads). The number of RBCs tended to be lower in PHZ-treated *Ttll4*-KO animals (3.77 × 10^6^/mm^3^) than in PHZ-treated wild-type animals (4.61 × 10^6^/mm^3^; [Figure 3B](#F3){ref-type="fig"}).

![RBC morphology of wild-type and *Ttll4*-KO mice under oxidative stress. (A) Giemsa-stained RBCs 2 d after PHZ treatment. Scale bar, 10 μm. Arrowheads, lysed RBCs. (B) Quantitative analysis of the average number of RBCs before and after PHZ treatment. (C) Fold-percentage decrease in the number of RBCs by PHZ treatment in individual wild-type and *Ttll4*-KO mice. Data are shown as mean ± SEM of fold-percentage decrease (4 mice per group; \**p* \< 0.05). (D) Morphology of the spleen of untreated and PHZ-treated wild-type and *Ttll4*-KO mice. Scale bar, 1 cm. (E) Quantitative analysis of relative weight of spleen to body weight (spleen-to-body weight ratio). Data are shown as mean ± SEM (untreated: wild type *N* = 3, *Ttll4*-KO *N* = 4; PHZ treated: *N* = 4 for both wild type and *Ttll4*-KO; \**p* \< 0.05). Mice 8--12 mo of age regardless of the sex were used for each experiment.](535fig3){#F3}

Given that the number of steady-state RBCs in *Ttll4*-KO mice was slightly higher than that in wild-type mice ([Figure 3B](#F3){ref-type="fig"}), we calculated and compared the percentage fold decrease of RBCs after PHZ treatment. The fold decrease was ∼50% in *Ttll4*-KO mice, whereas that in wild-type mice was ∼29%, showing a significant difference ([Figure 3C](#F3){ref-type="fig"}).

Finally, we examined the effect of PHZ treatment on spleen morphology. Pronounced splenomegaly was observed in *Ttll4*-KO mice under PHZ administration ([Figure 3D](#F3){ref-type="fig"}). In addition, the weight of the spleen relative to the body weight of *Ttll4*-KO mice was 1.3-fold higher than that for wild-type mice under PHZ administration ([Figure 3E](#F3){ref-type="fig"}).

*Ttll4*-KO RBCs have abnormal cytoskeletal architecture beneath the plasma membrane
-----------------------------------------------------------------------------------

The foregoing findings prompted us to investigate the organization of the membrane skeleton of RBCs for underlying defects. We used transmission electron microscopy (TEM) to visualize the membrane skeleton of RBC ghosts that were fixed with glutaraldehyde, negatively stained with uranyl acetate, and attached to copper grids coated with Formvar and carbon. TEM revealed a noticeable difference in the meshwork between *Ttll4*-KO and wild-type RBCs. Magnified photographic images revealed that the meshwork had uncharacteristic "holes" in the membrane skeleton in *Ttll4*-KO RBCs ([Figure 4A](#F4){ref-type="fig"}). However, individual actin-spectrin lattices were not visible in the electron micrographs. On average, there were 9.5 holes/μm in *Ttll4*-KO RBCs, whereas the wild-type RBC membrane skeleton had a higher density of holes, with 12.6 holes/μm ([Figure 4B](#F4){ref-type="fig"}).

![RBC membrane cytoskeleton displays abnormal macromolecular aggregation in the absence of *Ttll4*. (A) Electron micrographs of unspread RBC membrane ghosts from wild-type and *Ttll4*-KO mice. Top, low-power microscopic images showing entire membrane ghosts; scale bar, 500 nm. Middle, high-power microscopic images of the samples shown at top; scale bar, 250 nm. Bottom, magnified images of the high-power images showing meshwork with irregular holes and normal holes in *Ttll4*-KO and wild-type RBC membrane ghosts, respectively; scale bar, 15 nm. (B) Quantitative analysis of the number of holes on a scanned line. Data are shown as mean ± SEM (wild type: 24 cells from four independent mice; *Ttll4*-KO: 22 cells from four independent mice; \**p* \< 0.05). Mice 8--12 mo of age regardless of the sex were used for each experiment.](535fig4){#F4}

Glutamylated NAP1 is concentrated in the RBC membrane and is lost in *Ttll4*-KO RBCs
------------------------------------------------------------------------------------

We analyzed whole RBC lysates prepared from wild-type and *Ttll4*-KO mice by Western blot analysis with a monoclonal antibody (mAb) specific for glutamylation---GT335---in order to identify which protein(s) were glutamylated in a TTLL4-dependent manner in RBCs. We detected a ∼60-kDa protein as the sole major band in whole lysates of wild-type RBCs; this band disappeared in *Ttll4*-KO samples ([Figure 4A](#F4){ref-type="fig"} and Supplemental Figure S2). We next performed immunoprecipitation to determine which protein was detected with the glutamylation-specific mAb GT335. The ∼60-kDa protein that was immunoprecipitated with the mAb GT335 from wild-type RBC lysates was detected using an anti-NAP1 antibody ([Figure 5B](#F5){ref-type="fig"}). No NAP1 was precipitated from the *Ttll4*-KO RBC lysate with the mAb GT335 ([Figure 5B](#F5){ref-type="fig"}). In addition, the mAb GT335 recognized NAP1 immunopurified from the wild-type RBC lysate but did not detect the protein purified from the *Ttll4*-KO RBC lysate ([Figure 5C](#F5){ref-type="fig"}). Of note, a slight decrease in the molecular weight of NAP1 was observed in *Ttll4*-KO RBC samples ([Figure 5, B and C](#F5){ref-type="fig"}).

![TTLL4 modifies NAP1 in RBCs. (A) Immunoblot showing 60-kDa glutamylated protein in whole red blood lysate of wild-type and *Ttll4*-KO mice. mAb GT335 was used to detect glutamylation. (B) Immunoblots (IB) after immunoprecipitation (IP) of 60-kDa glutamylated protein from RBC lysate performed with GT335 antibody. (C) Proteins immunoprecipitated with anti-NAP1 antibody. (D) Confocal microscopy images after immunohistochemistry showing NAP1 (magenta) in RBCs. TER-119 (green) is the erythroid marker. Scale bar, 5 μm. (E) Immunoblotting analysis of levels of glutamylated NAP1 in cytosolic and membrane fraction of wild-type and *Ttll4*-KO RBCs. Carbonic anhydrase1 (CA1) and glycophorin A (GPA) were used as cytosolic and membrane markers, respectively. (F) Quantification of glutamylation levels of NAP1 as described in E. Data are shown as mean ± SEM (three mice per group; \**p* \< 0.05). Mice 8--12 mo of age regardless of the sex were used for each experiment.](535fig5){#F5}

We next analyzed the intracellular localization of glutamylated NAP1 in RBCs. Immunocytochemical analyses showed that total NAP1 was localized predominantly in the cytosol in both wild-type and *Ttll4*-KO RBCs ([Figure 5D](#F5){ref-type="fig"}). Thus we fractionated the cytosolic and membranous components of RBCs and analyzed these samples by Western blotting. We loaded 80-fold more protein from the membranous fraction than from the cytosolic fraction to obtain nearly comparable NAP1 levels in both the membranous and cytosolic fractions, given the predominant localization of NAP1 in the RBC cytosol. In wild-type RBCs, the band for glutamylated NAP1 appeared to be more intense in the membranous fraction than in the cytosolic fraction ([Figure 5E](#F5){ref-type="fig"}). Quantitative and statistical analyses of the Western blotting results showed that the glutamylation level of NAP1 in the membranous fraction was nearly double that in the cytoplasmic fraction (1.39 vs. 0.73 arbitrary units; [Figure 5F](#F5){ref-type="fig"}). Glutamylated NAP1, which was normally concentrated in the membrane, was completely lost in the *Ttll4*-KO RBC membrane ([Figure 5E](#F5){ref-type="fig"}).

Glutamylation of NAP1 is important for its binding with the RBC membrane
------------------------------------------------------------------------

Coomassie blue--stained gels and Western blot analysis of RBC Mg^2+^ ghosts and the Triton X-100--insoluble membrane skeleton revealed normal amounts of the major proteins α-spectrin, β-spectrin, band 3, protein 4.1, protein 4.2, and actin in the *Ttll4*-KO RBC membrane ([Figure 6, A and B](#F6){ref-type="fig"}). Moreover, levels of the actin-binding proteins α-adducin, β-adducin, tropomodulin 1, and tropomyosin remained nearly unchanged in the *Ttll4*-KO RBC membrane ([Figure 6, A and B](#F6){ref-type="fig"}). NAP1 was detected in both Mg^2+^ ghosts and Triton-insoluble membrane skeleton fractions of both wild-type and *Ttll4*-KO RBCs ([Figure 6A](#F6){ref-type="fig"}).

![TTLL4-mediated glutamylation of NAP1 controls NAP1 interaction with RBC membrane. (A) Coomassie-stained gel and immunoblots showing the comparison of Mg^2+^ ghosts and Triton-insoluble cytoskeleton protein composition in wild-type and *Ttll4*-KO RBCs. Coomassie brilliant blue (CBB) staining served as a loading control for the normalization of protein levels. (B) Quantification of levels of α-spectrin, α-adducin, β-adducin, actin, tropomodulin 1, tropomyosin (TM5NM1), and NAP1 proteins in Mg^2+^ ghosts and Triton-insoluble cytoskeleton of RBCs as described in A. Data are shown as mean ± SEM (three mice per group; \**p* \< 0.05). (C) Immunoblots showing the levels of NAP1 from wild-type and *Ttll4*-KO RBC membranes in different salt concentrations. CBB staining served as a loading control for the normalization of NAP1 levels. (D) Quantification of levels of glutamylated and nonglutamylated NAP1 in total membrane fraction as described in C. Data are shown as mean ± SEM (three mice per group; \**p* \< 0.05). (E) Quantification of levels of glutamylated and nonglutamylated NAP1 in supernatant and remaining membrane pellet as a ratio of supernatant to the pellet as described in C. Data are shown as mean ± SEM (three mice per group; \**p* \< 0.05, paired *t* test). Mice 8--12 mo of age regardless of the sex were used for each experiment.](535fig6){#F6}

To determine the effect of TTLL4-mediated glutamylation of NAP1 on its interaction with membrane proteins, we incubated wild-type and *Ttll4*-KO Mg^2+^ membrane ghosts in increasing concentrations of KCl and then evaluated NAP1 levels in both the supernatant and the remaining membrane pellet fractions. The total amounts of NAP1 were similar in the wild-type and *Ttll4*-KO RBC membranes ([Figure 6, C](#F6){ref-type="fig"}, left, and [D](#F6){ref-type="fig"}). The levels of NAP1 released from the wild-type and *Ttll4*-KO RBC membranes into the supernatant increased, depending on the salt concentration; NAP1 release was lower at lower salt concentrations and higher at higher salt concentrations ([Figure 6, C and E](#F6){ref-type="fig"}). In addition, at 210 and 310 mM KCl, more NAP1 was released into the supernatant from the *Ttll4*-KO RBC membrane than from the wild-type RBC membrane ([Figure 6, C](#F6){ref-type="fig"}, middle, and [E](#F6){ref-type="fig"}).

DISCUSSION
==========

RBCs of *Ttll4*-KO mice appeared normal under aldehyde-fixed or intact conditions but were flattening and showed a higher variance of mean diameters in the smear test. We inferred that the observed changes in the RBC phenotypes in smear were due to the morphological vulnerability of *Ttll4*-KO RBCs under stress rather than actual differences in the sizes of RBCs. Similarly, *Ttll4*-KO RBCs were more vulnerable than control RBCs to hemolysis caused by PHZ-induced high oxidative stress. One plausible explanation for this observation is that *Ttll4*-KO RBC membrane proteins may undergo more oxidative cross-linking. This enhanced oxidative sensitivity may be due to primary structural/functional defects in the membrane cytoskeleton of *Ttll4*-KO RBCs ([@B3]; [@B10]). Consistent with these results, ultrastructural analyses revealed uncharacteristic holes beneath the plasma membrane of RBCs in *Ttll4*-KO mice, suggesting macromolecular aggregation/instability of cytoskeletal components, presumably caused by primary structural/functional defects in *Ttll4*-KO RBCs. These results appeared to be corroborated by prior evidence showing that defective cytoskeleton proteins result in cytoskeletal protein aggregation ([@B19]; [@B5]).

The abnormal macromolecular aggregation detected in the *Ttll4*-KO RBC cytoskeleton could be explained in terms of inappropriate molecular interactions. Electrostatic interactions determine the adhesion of the skeleton to the substrate, and tighter binding prevents the cytoskeletal components from moving together and condensing ([@B36]). On the basis of this background, we hypothesize that *Ttll4*-KO RBC cytoskeletal proteins may have altered ionic interactions, preventing their tight binding to the substrate and resulting in aggregation of the components. Glutamylated NAP1 could be responsible for maintaining proper ionic interactions among proteins, and the lack of glutamylation on NAP1 disrupted this balance ([Figure 6, C and E](#F6){ref-type="fig"}). More discussion on salt-induced NAP1 release is presented later.

Our data showed that NAP1 was the only glutamylated protein in whole RBC lysates ([Figure 5A](#F5){ref-type="fig"}). These data indicate that NAP1 is either the only substrate of the TTLL4 enzyme in mature RBCs or that other glutamylated substrates are present below the detection limit of the mAb GT335. Our results showing the higher levels of glutamylated NAP1 in the RBC membrane and the morphology of the cytoskeleton suggest that glutamylated NAP1 may have a role in cytoskeletal protein dynamics through its chaperone activity. NAP1 interacts with a wide array of proteins involved in many cellular processes, including roles related to histone chaperone characteristics and exchange of proteins ([@B41]). In *Xenopus laevis* eggs, NAP1 chaperone activity is important for normal binding and deposition of the linker histone H1M to chromatin; glutamylation is essential for H1M dynamics in the cell cycle ([@B26]). TTLL4-mediated glutamylation indeed modulates the chaperone function of nucleoplasmin ([@B29]). In addition, some RBC cytoskeletal proteins are dynamic, and interaction and exchange of protein subunits occurs at the cytoskeleton ([@B13]). Thus glutamylated NAP1 may be required for proper deposition of these exchange factors at the membrane cytoskeleton.

The levels of glutamylated and nonglutamylated NAP1 released from the RBC membrane into the supernatant were increased, depending on the salt concentration, demonstrating that the interaction between NAP1 and the RBC membrane is electrostatic, irrespective of the glutamylation state. Under higher salt concentrations, the electrostatic interaction weakens; for example, the NAP1--histone complex dissociated as the concentration of sodium chloride increased ([@B30]). In addition, nonglutamylated NAP1 was more easily released into the supernatant than glutamylated NAP1 after incubation in increasing salt concentrations ([Figure 6, C and E](#F6){ref-type="fig"}), demonstrating that the lack of TTLL4-dependent glutamylation weakens NAP1 binding with the RBC membrane. The extra negative charge created by glutamylation on NAP1 may provide an acidic binding surface for other RBC cytoskeletal proteins. For NAP--histone binding, the acidic binding surface of the NAP1 dimer asymmetrically engages a single H2A--H2B heterodimer ([@B1]) and prevents nonspecific (i.e., nonnucleosomal) histone--DNA interactions ([@B2]). Of all the cytoskeletal proteins, only actin has been shown to bind NAP1 ([@B34]). The acidic binding surface on NAP1 could be a possible attachment site for actin, and TTLL4-dependent glutamylation may affect the ability of NAP1 to bind actin or other skeleton proteins, potentially acting as a linker between actin and other proteins. Moreover, the stability of actin from RBCs may be altered in the absence of NAP1 glutamylation because the extra negative charge on NAP1 contributes to the stability of the NAP1--protein complex ([@B30]).

We cannot rule out the possibility that a lack of TTLL4 in the bone marrow may affect the development and maturation of RBCs because TTLL4 is highly expressed in this tissue ([Figure 1E](#F1){ref-type="fig"}; [@B15]; [@B40]). TTLL4-mediated glutamylation of MAD2 is responsible for maturation of megakaryocytes in the bone marrow ([@B40]), and maturation of platelets in the peripheral blood also requires intense cytoskeletal reorganization ([@B5]; [@B17]). Although platelets and erythrocytes have different functions, both megakaryocytes and erythroid lineages proliferate from common megakaryocyte-erythroid progenitor cells in the bone marrow ([@B39]) and show similarities in differentiation, cytology, and homeostatic regulation ([@B21]; [@B22]). Other possibilities include that TTLL4-mediated glutamylation of PELP1, a chromatin remodeler, affects the epigenetic regulation of RBC development or the expression of protein components of RBC membranes ([@B20]).

Under steady-state conditions, the lack of *Ttll4* does not severely affect the function of RBCs, indicating that *Ttll4* plays a unique but subtle role in RBCs; further studies are needed to fully elucidate the functions of TTLL4 in this context and experimentally demonstrate how TTLL4-mediated glutamylation of NAP1 is important for RBCs. Thus the next step in determining whether NAP1 binds to actin and other membrane skeleton proteins, potentially acting as a linker between actin and other proteins, may involve identifying the NAP1 binding partners in the RBCs. Knowing the exact localization of glutamylated NAP1 on the membrane cytoskeleton through superresolution microscopy ([@B31]) and/or electron microscopy would further help to identify the role of glutamylated NAP1 in RBCs. In addition, recombinant NAP1 proteins and binding assays ([@B26]) could be used to check whether glutamylation affects the ability of NAP1 to bind to RBC membrane proteins. In addition, measuring the amount of actin in the supernatant after Triton X-100 extraction of whole RBCs in combination with FRAP analysis ([@B13]) should confirm the involvement of glutamylated NAP1 in the interaction and exchange of actin polymerization and depolymerization factors at the RBC cytoskeleton. Clearly, investigation of the proposed mechanisms would be vital for resolving the role of TTLL4-dependent glutamylation of NAP1 in RBCs.

In conclusion, we showed that proper RBC cytoskeletal organization requires the presence of the glutamylation-initiating glutamic acid ligase gene *Ttll4*.

MATERIALS AND METHODS
=====================

Antibodies
----------

Anti-TTLL4 antibody was raised in guinea pigs immunized with the glutathione *S*-transferase (GST)--fused C-terminal domain of TTLL4 (TTLL4 C′50AA). The polyclonal anti-Ttll4 antibody was purified using a column filled with the GST-tagged TTLL4 C-terminal domain (TTLL4 C′50AA). The fractionated anti-TTLL4 antibody was further precleared against TTLL4 KO tissue lysates. The mAb 4A8 for NAP1 was a kind gift from Yukio Ishimi (Ibaraki University, Mito, Japan). Other antibodies used in this study were as follows: polyglutamylation (mouse mAb GT335; AG-20B-0020-C100; AdipoGen, San Diego, CA); NAP1LI (rabbit polyclonal; ab33076; Abcam, Cambridge, United Kingdom); glycophorin A (mouse mAb; ab129024; Abcam); carbonic anhydrase1 (rabbit polyclonal; ab86280; Abcam); tropomyosin (mouse monoclonal; ab7785; Abcam); tropomodulin1 (mouse monoclonal; ab119025; Abcam); α-adducin (rabbit polyclonal; A303-713A; Bethyl Laboratories, Montgomery, TX); β-adducin (rabbit polyclonal; A303-741A; Bethyl); Ter119 (Alexa Fluor 488 anti-mouse TER-119/erythroid cells antibody; 116215; BioLegend, San Diego, CA); actin (rabbit polyclonal; A2066; Sigma-Aldrich, St. Louis, MO); spectrin β-chain (rabbit polyclonal; ABT185; Millipore, Billerica, MA), Alexa fluorophore--conjugated secondary antibodies for immunofluorescence (Invitrogen, Carlsbad, CA), and horseradish peroxidase--conjugated secondary antibodies for Western blot analysis (Jackson Immuno Research Laboratories, West Grove, PA).

Mice
----

All experiments and treatments in mice were approved by the Institutional Animal Care and Use Committee at the Hamamatsu University School of Medicine. *Ttll4* allele-trapped mice were purchased from Trans Genic (Kobe, Japan) and mated with wild-type C57BL/6J mice for at least 10 generations. *Ttll4*−*/*−, *Ttll4+/*−, and wild-type littermates were obtained from heterozygous mating. Mice 8--12 mo of age, regardless of the sex unless otherwise specified, were used for each experiment. The bone marrow and spleen were dissected from adult C57BL/6J wild-type and *Ttll4*−/− mice. The organs were homogenized in lysis buffer (50 mM Tris-Cl, pH 7.5, 1% Triton X-100). For the hemolytic anemia model, adult C57BL/6J and *Ttll4*−/− mice were injected with 20 mg/kg PHZ (Sigma-Aldrich; 114715) every 24 h for two consecutive days. Mice were killed at 48 h after injection, and hematological parameters were analyzed.

Genotyping of progenies by PCR
------------------------------

Genomic DNA was prepared from 4- to 5-mm tail samples and then used for genotyping by PCR. Oligonucleotides used were 5′-TTCTGTAGCTGGGCTTATT-3′ as the forward primer for the wild-type allele, 5′-AATCCCATGGTCCCACAAA-3′ as the forward primer for the trap vector, and 5′-CGGTGAAACCTCGACACA-3′ as the reverse primer for both the wild-type and trapped alleles.

Reverse transcription PCR
-------------------------

Total RNA was extracted from the testis and muscle tissues. Next 1 µg of RNA per sample was reverse-transcribed into cDNA with RTace (Toyobo, Osaka, Japan) and oligoT15 primer. The resulting cDNA was amplified with primers specific for *Ttll4*: forward, 5′-TATC TCGGAACTGTGTGGATTTGA-3′, and reverse, 5′-GAATGACCTGAATGCCAATGC-3′ and AmpliTaq Gold.

Blood collection and hematology analyses
----------------------------------------

Whole blood (200 μl) of adult *Ttll4*-KO and wild-type C57BL/6J was collected either via cardiac puncture or from the tail vein into Eppendorf tubes containing 2 μl of 10% EDTA or heparinized capillary tubes. RBC counts and indices were measured by an automated hematology analyzer (Celltac α; Nihon Kohden, Tokyo, Japan) calibrated for mouse blood. For Giemsa staining, whole-blood smears were air-dried, methanol-fixed, and stained with Giemsa. Peripheral blood counts were also determined by diluting RBCs in RBC diluting fluid (3% sodium citrate, 1% Formalin) and then by manual counting using a hemocytometer. Reticulocytes were counted manually after staining with new methylene blue (Sigma-Aldrich). Images were acquired with an Olympus BX51 microscope equipped with an Olympus DP-72 camera (Tokyo, Japan).

Osmotic fragility and deformability analysis
--------------------------------------------

Osmotic fragility was measured by the method of [@B12]. Whole blood was washed three times in isotonic buffer, and final hematocrit was adjusted to 5%. Diluted RBCs in a volume of 10 µl were added to 290 µl of lysis buffer of appropriate salt concentration and incubated for 20 min at room temperature. The lysed RBC suspension was then centrifuged, and the absorbance of the supernatant was measured at 540 nm. For measuring deformability, 30 µl of whole blood was mixed with 4 ml of 3.5% polyvinylpyrrolidone solution, and the deformability index was recorded by increasing applied sheer stress from 0 to 50 dynes/cm^2^ using a custom-built ektacytometer.

RBC purification and preparation
--------------------------------

We used three different methods to purify RBCs. RBCs were pelleted at 600 × *g* for 10 min at 4°C. After removal of the plasma and top cell layer, including the buffy coat, the cells were washed six times in RBC wash buffer (5 mM ethylene glycol tetraacetic acid \[EGTA\], 0.25% NaCl, 5.0 mM Na~2~HPO~4~, pH 7.5). Second, for purification by FACS, whole blood was washed once with PBS, and then 10 µl of blood was resuspended in FACS buffer (PBS, 0.5% bovine serum albumin \[BSA\], 1 mM EGTA, pH 7.5). The cell suspension was stained with TER-119 Alexa 488--conjugated antibody and then washed with PBS. Stained RBCs were sorted on a BD FACSAria (BD Biosciences, Franklin Lakes, NJ) and gated on the basis of their side scatter signals, forward scatter signals, and positive staining with TER-119 Alexa-488. The data were analyzed using FlowJo-V10 software. Third, a discontinuous gradient of 75% and 76.9% Percoll (Sigma-Aldrich) was used to separate RBCs.

Preparation of RBC membranes
----------------------------

To fractionate the soluble and membrane components of RBCs, washed RBCs were lysed with hypotonic buffer (20 mM Tris-Cl, 1 mM EGTA, pH 7.5), and the supernatant was separated by centrifugation. Next the cell pellet was washed repeatedly to remove all cytoplasmic content, and the final pellet consisting of RBC membrane ghosts was lysed directly in SDS--PAGE sample buffer, NP-40 lysis buffer, or RIPA buffer. The Mg^2+^ membrane ghosts and Triton-insoluble skeletons were prepared as described previously ([@B28]). Protein concentrations were measured using the BCA assay (Pierce, Rockford, IL). To determine the binding affinity of glutamylated and nonglutamylated NAP1 with the RBC membrane, Mg^2+^ membrane ghosts were treated with increasing concentrations (110, 210, and 310 mM) of KCl in a medium of lysis buffer (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 1 mM MgCl~2~, 1 mM EGTA, 1 mM dithiothreitol, 0.2% Triton X-100, 10% glycerol, pH 7.5) for 1.0 h and then centrifuged at 20,000 × *g* for 30 min at 4°C. After centrifugation, the supernatant was collected, and the remaining pellet was directly lysed in SDS--PAGE sample buffer.

Immunoprecipitation assay
-------------------------

To immunoprecipitate glutamylated proteins, mAb GT335 (Adipogen) was linked to protein G Sepharose beads (GE Healthcare, Little Chalfont, United Kingdom). For immunoprecipitation of NAP1LI, the anti-NAP1L1 antibody (Abcam) was linked to protein G Sepharose beads. The whole RBC lysate was added to the beads and incubated overnight at 4°C. Bound proteins were directly eluted in SDS--PAGE sample buffer.

Immunoblotting and immunofluorescence
-------------------------------------

SDS--PAGE was performed as described by [@B42]. Fairbanks running buffer ([@B9]) was used to separate ankyrin from the spectrins. Gels were either stained with Coomassie blue or transferred to polyvinylidene fluoride membranes (Millipore) for immunoblotting. The membranes were probed with various primary antibodies, followed by horseradish peroxidase--conjugated secondary antibodies. Blots were developed with enhanced chemiluminescence reagents (ECL; GE Healthcare) and exposed in a Fuji Film Intelligent Dark Box (Tokyo, Japan), where the images were captured using Image Reader LAS-3000 software. For immunohistochemistry, RBC samples were washed three times with PBS (330 mOsm) containing 5 mM glucose, fixed for 20 min in 4% paraformaldehyde and 0.02% glutaraldehyde in PBS at room temperature, and rinsed three times in rinsing buffer (PBS containing 0.1 M glycine). Fixed cells were then permeabilized with PBS containing 0.1 M glycine and 0.1% Triton X-100 for 5 min at room temperature and again rinsed three times in PBS containing 0.1 M glycine. To ensure complete neutralization of the unreacted aldehydes, RBCs were then incubated in rinsing buffer at room temperature for 1.5 h. Nonspecific binding was blocked by incubation in blocking buffer (PBS containing 0.05 mM glycine, 0.2% BSA, and 5% goat serum) overnight at 4°C. After immunostaining, RBCs were allowed to attach to glass coverslips for 20 min in a humidified chamber and mounted on glass slides using Vectashield mounting medium for fluorescence (Vector Laboratories, Burlingame, CA) and observed by confocal laser scanning microscopy (FluoView FV1000; Olympus).

Ultrastructure studies
----------------------

For SEM, whole blood was fixed with 2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, and postfixed in 1% OsO~4~. Next the fixed cells were dehydrated, freeze-dried, and plasma-coated. The cells were photographed using a Hitachi S-4800 scanning electron microscope. For TEM of the RBC membrane skeleton, copper grids of 400 mesh (Nisshin-EM, Tokyo, Japan) were coated with 0.5% (wt/vol) Formvar in ethylene dichloride ([@B7]) and then were carbon-coated and subjected to glow discharge (HDT-400 Hydrophilic Treatment Device; JEOL Datum, Tokyo, Japan). Collected blood cells were washed with PBS containing Mg and EGTA (Pi/NaCl/Mg; 150 mM NaCl, 5 mM NaH~2~PO~4~, 2 mM NaN~3~, 2 mM MgCl~2~, 1 mM EGTA, pH 5.5). Washed RBCs were then coated onto the grids as described by [@B4]. Of note, the protocol by [@B4] is for spreading the RBC skeleton on the grid; however, our results ([Figure 3A](#F3){ref-type="fig"}) indicate that the RBC membranes were not spread and remained at native mouse RBC size. TEM images of RBC membranes were obtained using a JEOL JEM-1220 transmission electron microscope with an accelerating voltage of 80 kV and equipped with a Gatan-Bioscan camera, Model 792 (Pleasanton, CA).

Image and statistical analyses
------------------------------

ImageJ software (<http://rsb.info.nih.gov/ij/index.html>) was used for densitometry analysis of Western blot data to measure the diameter of RBCs and for counting the holes in the RBC cytoskeleton. To calculate the coefficient of variance (CV), the means of RBC diameters acquired from each individual mouse were calculated. The mean diameters were used as representatives for each individual animal. The differences between the highest and lowest mean diameter of each genotype were used as values of variation. The coefficient of variance was calculated as CV = σ/μ, where σ is SD and μ is mean diameter. To count the holes in the RBC membrane cytoskeleton, individual transmission electron micrographs were converted into binary format, plot profiles were measured, and the obtained peaks were counted manually. The histogram for RBC diameter was prepared in MATLAB. The significance of differences in the means was evaluated using the Student's two-tailed *t* test unless otherwise specified. *p* \< 0.05 was considered significant. The results are expressed as mean ± SEM; *n* is the number of cells, and *N* is the number of animals.
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KO

:   knockout

NAP1

:   nucleosome assembly protein 1

PHZ

:   phenyl­hydrazine

RBCs

:   red blood cells

TTLL

:   tubulin tyrosine ligase--like

[^1]: ^†^The institute was closed in March 2009.
